Literature cited
L. N. Borisova, O. M. Glozman, Sh. I. Ismailov, et al., Khim.-farm. Zh., No. 1, 41–45 (1989).
V. S. Gasilin and B. A. Sidorenko, Stenocardia.(in Russian], Moscow (1981).
O. M. Glozman, L. N. Borisova, V. I. Kuz'min, et al., Khim.-farm. Zh., No. 1, 38–41 (1989).
I. V. Duba, G. I. Gerasimovich, and A. I. Balakleevskaya, Akush. Ginekol., No. 10, 32–35 (1981).
V. N. Ermakova, Vestn. Oftal'mol., No. 5, 10–13 (1981).
I. V. Komissarov and I. I. Abramets, Usp. Fiziol. Nauk, No. 2, 75–93 (1977).
D. V. Preobrazhenskii, Ter. Arkh., No. 12, 123–128 (1984).
D. P. Polukordas and V. V. Daukshas, New Drugs [in Russian], Moscow (1975), pp. 26–52.
I. B. Simon, V. P. Vvedenskii, I. I. Levshina, et al., Khim.-farm. Zh., No. 3, 7–9 (1974).
E. I. Chazov and V. I. Metelitsa, ibid., No. 10, 3–12 (1979).
V. F. Shmyreva, N. V. Fridman, and N. V. Makasheva, Vestn. Oftal'mol., No. 3, 8–10 (1982).
E. V. érina, Kardiologiya, No. 9, 114–121 (1980).
B. Ablad and E. Ek. L. Caisson, Life Sci.,12, 107–112 (1973).
K. R. Adam, J. R. C. Baird, R. A. Burges, and J. Linnell, Eur. J. Pharmacol.,25, 170–175.
W. H. Aellig, Br. J. Pharmacol.,47, 621P (1973).
W. H. Aellig, J. Cardiovasc. Pharmacol.,5, Suppl. 1, 516–520 (1983).
G. Allan, D. Cambridge, G. W. Hardy, et al., J. Hypertens.,4, Suppl. 6, 131–133 (1986).
H. L. Ammon, K. El-Sayed, S. M. Prasad, et al., Acta Crystallogr.,42, 446–452 (1986).
Y. Antonio, C. Camargo, E. Galearri, et al., J. Med. Chem.,21, 123–126 (1978).
E. J. Ariens and A. M. Simonis, Beta-Adrenoreceptor Blocking Agents, Amsterdam (1976), pp. 3–27.
W. S. Aronow and R. R. Uyeyama, Clin. Pharmacol. Ther.,13, 15–22 (1982).
D. Atlas, M. L. Steer, and A. Levitzki, Proc. Natl. Acad. Sci.,73, 1921–1925 (1976).
J. J. Augstein, D. A. Cox, A. L. Ham, et al., J. Med. Chem. 16, 1245–1251 (1973).
J. J. Baldwin, E. L. Engelhardt, R. Hirschmann, and G. S. Ponticello, ibid.,23, 65–70 (1980).
J. J. Baldwin, G. H. Denny, R. Hirschmann, et al., ibid.,26, 950–957 (1983).
J. J. Baldwin, M. E. Christy, G. H. Denny, et al., ibid.,29, 1065–1080 (1986).
J. J. Barlow, B. G. Main, J. A. Moors, et al., Br. J. Pharmacol.,67, 412–418 (1979).
J. J. Barlow, B. J. Main, and H. M. Snow, J. Med. Chem.,24, 315–322 (1981).
A. M. Barrett, Drug Design, Vol. 3, London (1972), pp. 205–228.
A. M. Barrett, J. Carter, J. D. Fitzgerald, et al., Br. J. Pharmacol.,48, 340P (1973).
W. Bartsch, K. Dietmann, J. Leinert, and G. Sponer, Arzneim.-Forsch.,27, 1022–1026 (1977).
W. Bartsch, G. Sponer, K. Strien, et al., Therapiewoche,32, 5714–5719 (1982).
B. Basil and R. Jordan, Eur. J. Pharmacol.,80, 47–56 (1982).
R. Berthold, R. Waite, and H. Weber, Br. J. Pharmacol.,74, 829P (1981).
J. P. Bilezikian, A. M. Dornfeld, and D. Gammon, Biochem. Pharmacol.,27, 1455–1461 (1978).
A. Bilski, S. Dorries, and J. D. Fitzgerald, Br. J. Pharmacol.,69, 292P (1980).
J. W. Black and J. S. Stephenson, Lancet,2, 311–314 (1962).
J. W. Black, A. F. Crowter, R. G. Shanks, et al., ibid.,1, 1080–1081 (1964).
J. R. Boissier, R. Ratouis, C. Dumont, et al., J. Med. Chem.,13, 971–973 (1970).
J. R. Boissier, R. Goutte, C. Advenier, and J.-F. Giudicelli, Therapie,28, 1251–1265 (1973).
J. P. Boudot, J. Cavero, S. Fenard, et al., Br. J. Pharmacol.,66, 445P (1979).
E. Bouley, J.-M. Teulin, M. Cazes, et al., J. Med. Chem.,29, 100–103 (1986).
M. Bouzoubaa, G. Leclerc, N. Decker, et al., ibid.,27, 1291–1294 (1984).
A. Brandstrom, H. Corrodi, U. Junggren, and T. E. Jonsson, Acta Pharm. Suec.,3, 303–310 (1966).
Brefonalol, Drug License Opport., Dec. 5 (1988), p. 2051.
J. J. Burgess, Med. Prog.,13, 22–31 (1986).
M. Carissimi, P. Gentili, E. Grumelli, et al., Arzneim.-Forsch.,26, 506–516 (1976).
M.-Ch. Carre, A. Youlassani, P. Caubere, et al., J. Med. Chem.,27, 792–798 (1984).
S. G. Carruthers, J.-P. Hosler, P. Pentikainen, and D. L. Azarnoff, Clin. Pharmacol. Ther.,24, 168–174 (1978).
C. Castagnino, S. Corsaco, G. Strappaghetti, et al., Farmaco, Ed. Sci.,38, 679–685 (1983).
I. Cavero, F. Levevre-Borg, and P. Manoury, Br. J. Pharmacol.,84, Suppl., P 31P (1985).
V. Cecchetti, et al., Farmaco, Ed. Sci.,42, 61–75 (1987).
M. S. Chodnecar, A. F. Crowther, W. Hepworth, et al., J. Med. Chem.,15, 49–57 (1972).
B. J. Clark, K. Saameli, and F. Troxter, Proc. Br. Pharmacol. Sci., 123 (1974).
B. J. Clark, Beta-Adrenoreceptor Blocking Agents, Amsterdam (1976), pp. 45–78.
B. J. Clark, Vasc. Med.,2, 17–25 (1985).
M. A. Commarato, H. C. Giardino, G. A. Kopin, and H. R. Kaplan, Arch. Int. Pharmacodyn. Ther.,226, 205–212 (1977).
S. Conde, C. Corral, R. Madronero, et al., J. Med. Chem.,20, 970–974 (1977).
S. Conde, C. Corral, J. Lissavetzky, et al., Eur. J. Med. Chem.,18, 151–154 (1983).
M. E. Condon, C. M. Gimarusti, R. Fox, et al., J. Med. Chem.,21, 913–921 (1978).
H. Corradi, H. Persson, A. Carlsson, and J. Roberts, ibid.,6, 751–755 (19630.
C. R. Crooks, J. Wright, P. S. Callery, and J. E. Moreton, ibid.,22, 210–214 (1979).
A. F. Crowther and L. H. Smith, ibid., 1009–1013 (1968).
A. F. Crowther, D. J. Gilman, B. J. McLoughlin, et al., ibid.,12, 638–646 (1969).
A. F. Crowther, R. Howe, B. J. McLoughlin, et al., ibid.,15, 260–266 (1972).
J. W. Daemmgent, G. Engelhardt, and H. Pelzer, Arzneim.-Forsch.,35, 383–390 (1985).
R. C. Dage, H. C. Cheng, C. P. Hsich, and J. K. Woodward, Fed. Proc.,37, 633–647 (1978).
P. Da Re, P. Valenti, G. Fabbri, et al., Drugs Exp. Res.,14, 687–692 (1988).
C. T. Dollery, J. Cardiovasc. Pharmacol.,11, Suppl. 2, 1–4 (1988).
D. J. Dooley and H. Bittager, International Congress of Pharmacology, No. 9, Abstracts, London (1984), p. 1009P.
L. Dorigotti, G. Ferni, and C. Semerazo, ibid., 1906P.
B. Dubois and M. G. Bousser, Therapie,40, 407–412 (1985).
D. Dunlop and R. G. Shanks, Br. J. Pharmacol.,32, 201–208 (1968).
L. H. Easson and E. Stedman, Biochem. J.,27, 1257–1266 (1933).
J. A. Edwards, B. Berkoz, G. S. Lewis, et al., J. Med. Chem.,17, 200–203 (1974).
P. W. Erhardt, C. M. Woo, W. C. Andersson, and R. J. Gorczynski, ibid.,25, 1408–1412 (1982).
A. Eschalier, G. Dureng, P. Duchene-Marullas, et al., Eur. J. Med. Chem.,18, 139–145 (1983).
M. Ezer, G. Shtacher, and M. Weinstock, J. Med. Chem.,21, 982–984 (1978).
J. Farmer, I. Kennedy, G. P. Levy, and R. J. Marshall, Br. J. Pharmacol.,45, 660–675 (1972).
J. Feely and N. Peden, Drugs,27, 425–446 (1984).
M. G. Fekete, Arch. Int. Pharmacodyn. Ther.,248, 190–202 (1980).
K. Femmer, R. Bartsch, U. Leonhardt, et al., Pharmazie,30, 642–651 (1975).
R. Ferrini, G. Miragoli, and G. Croce, Arzneim.-Forsch.,20, 1074–1079 (1970).
L. J. Findley and I. Cleeves, Lancet,1, 856 (1988).
G. A. Fothergill, Arzneim.-Forsch.,27, 978–981 (1977).
A. Franke, F. F. Frickel, J. Gries, et al., ibid.,30, 1831–1838 (1980).
A. Frankel, F. F. Frickel, J. Gries, et al., J. Med. Chem.,24, 1460–1464 (1981).
W. H. Frishman, Am. Heart J.,98, 526–535 (1979).
W. H. Frishman, ibid., 119–131.
W. H. Frishman, Clinical Pharmacology of β-Adrenergic Blocking Drugs, New York (1980).
W. H. Frishman, N. Engl. J. Med.,305, 500–506 (1981).
W. H. Frishman, Int. J. Cardiol.,2, 165–178 (1982).
W. Fuhrer, F. Ostermayer, K. Zimmermann, et al., J. Med. Chem.,27, 831–836 (1984).
H. Galons, C. C. Farnoux, and M. Miocque, Eur. J. Med. Chem.,19, 23–27 (1984).
L. Garuti, A. Ferranti, G. Giovanninetti, and R. Gaggi, Farmaco, Ed. Sci.,38, 527–532 (1983).
J. F. Giudicelli, Therapie,35, 23–43 (1980).
T. Grandjean and L. Rivier, Cardiologia,49, 139–141 (1966).
J. Gries, L. Unger, J. Eining, et al., Arzneim.-Forsch.,38, 1271–1279 (1988).
D. Grimes, M. Stern, A. Wojdan, and J. R. Cummings, Can. J. Physiol. Pharmacol.,61, 1109–1115 (1983).
C. Guechot, A. Bertrand, P. Cramaille, and J. M. Teulon, Arzneim.-Forsch.,38, 655–660 (1988).
Y. Hara, E. Sato, A. Mivagishi, et al., Jpn. J. Pharmacol.,28, Suppl., 140P (1978).
S. G. Hasting, R. D. Smith, R. M. Corey, et al., Arch. Int. Pharmacodyn. Ther.,226, 81–99 (1977).
R. C. Heel, R. N. Brogden, T. M. Speight, and G. S. Avery, Drugs,17, 38–55 (1979).
B. A. Hemsworth and J. A. Street, International Congress of Pharmacology, No. 7, Abstracts (Paris, 1978), p. 962.
P. H. Hernandez, H. E. Lape, and R. E. Philion, Fed. Proc.,38, 738–739 (1979).
N. Himori, A. Izumi, and Y. Hiramatsu, Arch. Int. Pharmacodyn. Ther.,220, 4–18 (1976).
W. Hoefke, W. Gaida, and A. Mentrup, Naunyn-Schmiedeberg's Arch. Pharmacol.,325, 1254 (1984).
M. L. Hoefle, S. G. Hastings, R. F. Meyer, et al., J. Med. Chem.,18, 148–152 (1975).
J. Hoekenda, L. David, and J. Abrams, Am. J. Med.,76, 309–314 (1984).
D. Horii, T. Kawada, K. Takeda, and S. Imai, Arzneim.-Forsch.,24, 1275–1286 (1974).
R. Howe and B. S. Rao, J. Med. Chem.,11, 1118–1121 (1968).
R. Howe, B. J. McLoughlin, B. S. Rao, et al., ibid.,12, 452–458 (1969).
R. Howe, B. S. Rao, and M. S. Chodnekar, ibid.,13, 169–176 (1970).
H. Hubner, K. Stephen, W. Meesmann, and R. R. Alendroth, Arzneim.-Forsch.,26, 1561–1565 (1976).
K. Ikezono, Jpn. J. Pharmacol., Suppl.,28, 149P (1978).
H. Imamura, T. Nakamura, J. Inui, et al., Yakugaku Zasshi,92, 1039–1045 (1972).
J. L. Imbs, F. Miesch, and J. Schwartz, Br. J. Pharmacol.,60, 357–362 (1977).
R. Jackdish, M. Lederle, and G. Hertting, Arzneim.-Forsch.,35, 237–240 (1985).
H. Jacob, L. J. Brandt, F. Farkas, and W. Frishman, Am. J. Med.,74, 1042–1051 (1983).
B. Jamart-Gregoire, P. Caubere, M. Blank, et al., J. Med. Chem.,32, 315–320 (1989).
T. Jen and C. Kaiser, ibid.,20, 693–699 (1977).
G. Jennings, A. Bobik, and P. Korner, Br. J. Clin. Pharmacol.,12, 355–362 (1981).
S. T. Kam, W. L. Matier, K. X. Mai, et al., J. Med. Chem.,27, 1007–1016 (1984).
I. M. Katz, Ann. Ophthalmol.,10, 847–850 (1978).
J. Kennedy and G. P. Levy, Br. J. Pharmacol.,53, 585–592 (1975).
A. M. Khokhar, P. de Silva, R. F. Massey, and C. W. H. Havard, International Society of Hypertension, 6th Scientific Meeting, Coteborg (1979), Abstracts, p. 144.
R. W. Kierstead, A. Faraone, F. Mennona, et al., J. Med. Chem.,26, 1561–1569 (1983).
K. H. Klinger, Drugs of the Future,7, 825–826 (1982).
W. E. Kreighbaum, W. L. Matier, R. D. Dennis, et al., J. Med. Chem.,23, 285–289 (1980).
K. Kubo, J. Nakamura, A. Karassawa, et al., Arzneim.-Forsch.,33, 926–931 (1983).
L. Lallos, V. Lappinet, G. Couderi, et al., J. Med. Chem.,24, 994–1001 (1981).
M. S. Large and L. H. Smith, ibid.,25, 1417–1422 (1982).
A. A. Larsen and P. M. Lish, Nature,203, 1283–1284 (1964).
M. Laubie, H. Schmitt, P. Mouille, et al., Arch. Int. Pharmacodyn. Ther.,201, 334–346 (1973).
G. Leclere, A. Mann, G. G. Wesmuth, et al., J. Med. Chem.,20, 1657–1662 (1977).
G. Leclerc, W. Bieth, and J. Schwartz, ibid.,23, 620–624 (1980).
G. Leclerc, Highlights Receptor Chemistry, Amsterdam (1984), pp. 109–133.
R. J. Lee, D. B. Evans, S. H. Baky, and R. J. Laffan, Eur. J. Pharmacol.,33, 371–382 (1975).
P. H. le Fur, G. Schelk, P. Geynet, et al., Life Sci.,23, 1841–1950 (1978).
T. L. Lemke, M. B. Cramer, and S. W. Adamski, J. Med. Chem.,24, 1211–1216 (1981).
G. Leopold, J. Pabst, W. Ungethum, and K. U. Buring, Clin. Pharmacol. Ther.,31, 243–249 (1982).
B. Levy, J. Pharmacol. Exp. Ther.,156, 452–462 (1967).
B. Levy and B. E. Wilkenfeld, Eur. J. Pharmacol.,5, 227–234 (1969).
C. Lindner, Arzneim.-Forsch.,34, 270–276 (1984).
W. J. Louis, M. J. Rand, and J. J. McNeill, Cardiology,66, 96–104 (1979).
W. J. Louis, O. H. Drummer, and L. H. Tung, J. Cardiovasc. Pharmacol.,11, Suppl. 2, S5-S11 (1988).
K. Lovgren and A. Hedberg, J. Med. Chem.,24, 451–454 (1981).
D. I. Lowenthal, S. D. Saris, J. Packer, et al., Am. J. Med.,77, 119–127 (1984).
B. Lundgren, E. Carlsson, and L. Ek, Acta Physiol. Scand.,44, 508–513 (1982).
B. Macchia, A. Balsamo, A. Lapucci, et al., J. Med. Chem.,30, 616–622 (1987).
P. J. Machin, D. N. Hurst, R. M. Bradshaw, et al., ibid.,26, 1570–1576 (1983).
J. A. Macrae, Trans. Ophthalmol. Soc.,97, 510–520 (1977).
B. G. Main, J. Chem. Technol. Biotechnol.,32, 617–623 (1982).
B. G. Main and H. Tucker, Prog. Med. Chem.,22, 122–163 (1985).
A. J. Man in'tVeld and M. A. D. H. Schlekamp, J. Cardiovasc. Pharmacol.,5, Suppl. 1, 30–45 (1983).
E. Marmo, A. P. Caputi, and K. Saini, Arzneim.-Forsch.,22, 1109–1117 (1972).
A. Martinand, P. Corvol, and P. Millier, Therapie,38, 265–272 (1983).
D. G. McDevitt and B. N. C. Prochard, H. R. Coll. Physicans London,11, 21–34 (1976).
D. G. McDevitt, Med. Prog.,11, 19–20 (1984).
F. B. McGillon, Drugs of the Future,6, 555–556 (1981).
R. F. Meyer, C. D. Stratton, S. C. Hasting, and R. M. Corey, J. Med. Chem.,16, 1113–1116 (1973).
E. J. Mylecharane and C. Raper, Eur. J. Pharmacol.,29, 93–101 (1974).
Y. Nakagawa, T. Sugai, W.-P. Chin, et al., Arzneim.-Forsch.,34, 194–199 (1984).
M. Nakanishi, I. Muro, Y. Chihara, et al., J. Med. Chem.,15, 45–48 (1972).
J. A. Nathanson, Br. J. Pharmacol.,73, 97–100 (1981).
W. C. Nayler and J. Tay, J. Pharmacol. Exp. Ther.,180, 302–316 (1972).
M. Neuman, Drugs of the Future,7, 96–97 (1982).
D. M. Nganele, V. M. Leonardis, and T. H. Hinze, Br. J. Pharmacol.,93, 501–508 (1988).
R. M. Nicholson, J. C. Dearden, and P. J. Blakedge, J. Pharm. Pharmacol.,35, 92P (1983).
A. Nuttall and H. M. Snow, Br. J. Pharmacol.,77, 381–388 (1982).
H. F. Oates, L. M. Stoker, and G. S. Stoker, Arch. Int. Pharmacodyn. Ther.,251, 95–102 (1981).
H. Obase, H. Tatsuno, K. Goto, et al., Chem. Pharm. Bull.,26, 1443–1452 (1978).
S. R. O'Donnell, W. Kaum, and J. C. Wanstall, Br. J. Pharmacol.,68, 705–710 (1980).
K. Ondrias, A. Stanko, V. Jancinova, and P. Balgavy, Mol. Pharmacol.,31, 97–103 (1987).
J. Pitha, B. A. Hughes, J. W. Kusiak, et al., Proc. Natl. Acad. Sci. USA,79, 4424–4427 (1982).
H. Pittner, Arzneim.-Forsch.,33, 13–25 (1983).
H. Pouleur, M. Rousseau, and L. A. Brasseur, Eur. J. Clin. Invest.,12, Suppl. 11, 49–55 (1982).
C. E. Powell and J. H. Slater, J. Pharmacol. Exp. Ther.,122, 480–488 (1958).
B. N. C. Prochard and C. W. Owens, Pharmacol. Ther.,11, 109–139 (1980).
B. N. C. Prochard, Drugs,28, Suppl. 2, 51–68 (1984).
B. N. C. Prochard, Clinical Pharmacology of Antianginal Drugs, Berlin (1985), pp. 385–458.
C. Raper, G. A. McPherson, and I. Iakovidis, Eur. J. Pharmacol.,52, 241–248 (1978).
D. P. Rauls and J. K. Baker, J. Med. Chem.,22, 81–86 (1979).
W. J. Rzeszotatski, R. E. Gibson, D. A. Simms, et al., ibid.,26, 644–648 (1983).
K. Saameli, Helv. Physiol. Pharmacol. Acta,25, 219–221 (1967).
J. Sato, Y. Kobayoshi, T. Nogasaki, et al., Chem. Pharm. Bull.,20, 905–917 (1972).
C. F. Schwender, S. Farber, C. Blaum, and J. Shavel, J. Med. Chem.,13, 684–688 (1970).
A. Scriabine, M. L. Torchiana, J. M. Stavorski, et al., Arch. Int. Pharmacodyn. Ther.205 76–93 (1973).
D. G. Shand, Drugs,25, Suppl. 2, 92–103 (1983).
S. Shibamura, T. Chiba, I. Suzuki, et al., Jpn. J. Pharmacol.,28, Suppl., 139P (1978).
G. Shtacher, R. Rubinstein, and P. Somani, J. Med. Chem.,21, 678–682 (1978).
V. Smeikal, Therapie,22, 2343–2347 (1967).
L. H. Smith and H. Tucker, J. Med. Chem.,20, 1653–1656 (1977).
L. H. Smith, J. Appl. Chem. Biotechnol.,28, 201–212 (1978).
P. Somani and A. R. Laddu, Eur. J. Pharmacol.,14, 209–216 (1971).
A. Squize and J. Kuqersmith, Mt. Sinai. J. Med.,22, 553–558 (1985).
U. Stache, W. Fritsch, and H. W. Fehlhaber, Arzneim.-Forsch.,37, 1217–1221 (1987).
K. Stock and E. Westermann, Biochem. Pharmacol.,14, 227–232 (1965).
T. L. Svendson, O. J. Hartling, J. Trap-Jensen, et al., Clin. Pharmacol. Ther.,29, 711–718 (1981).
C. S. Sweet, R. A. Hall, J. M. Columbo, et al., J. Pharmacol. Exp. Ther.,211, 195–199 (1979).
F. Takenaka, I. Ishikawa, and Y. Maruyama, Folia Pharmacol. Jap.,70, 385–397 (1974).
R. Takenaka and S. Tachikawa, Arzneim.-Forsch.,22, 1864–1869 (1972).
T. Takenaka, M. Asano, A. Berdeauz, and J.-F. Giudicelli, Eur. J. Pharmacol.,85, 35–50 (1982).
H. Tatsuno, K. Goto, K. Shigenobu, et al., J. Med. Chem.,20, 394–397 (1977).
N. E. Tayar, P. A. Carrupt, W. H. Vande, and B. Testa, ibid.,31, 2072–2081 (1988).
E. M. Taylor, D. Cameron, R. J. Eden, et al., J. Cardiovasc. Pharmacol.,3, 337–354 (1981).
U. M. Teotono, F. L. Polo, G. Steis, and D. Della Bella, J. Pharm. Pharmacol.,15, 26–33 (1963).
J. Trap-Jensen, J. E. Carlsen, T. L. Svendsen, and N. J. Christensen, Eur. J. Clin. Invest.,9, 181–189 (1979).
D. J. Triggle and C. R. Triggle, Chemical Pharmacology of the Synapse, London-New York (1976).
H. Tucker, J. Med. Chem.,23, 1122–1126 (1980).
H. Tucker, ibid.,24, 1364–1368 (1981).
Y. Uchida, M. Nakamura, S. Shimizu, et al., Arch. Int. Pharmacodyn. Ther.,262, 132–149 (1983).
V. Vechetti, F. Lauria, R. Tommasini, and M. Bergamaschi, Eur. J. Med. Chem.,9, 501–509 (1974).
L. Villa, E. Grana, C. Torlasco, and P. Pratesi, Farmaco. Ed. Sci.,24, 349–355 (1969).
A. Von de Water, W. Janssens, J. von Neuten, et al., J. Cardiovasc. Pharmacol.,11, 552–563 (1988).
G. Von Hatfelder, H. Lessenich, and K. Schmitt, Arzneim.-Forsch.,22, 930–940 (1972).
A. Von Mollendorf, C. Huschka, E. Schroter, and U. Abchagen, Clin. Sci.,61, 477–479 (1981).
J. L. Wale, J. Convay, M. Reeves, and M. Austin, Clin. Pharmacol. Physiol.,6, 11–19 (1979).
L. R. Williams, B. V. Lap, C. H. Lim, et al., J. Med. Chem.,21, 1081–1084 (1978).
P. U. Witte, M. H. Budian, P. Hajdu, and V. Malerczyk, Naunyn-Schmiededberg's Arch. Pharmacol.,322, 131R (1983).
K. R. H. Wooldridge, Experientia,28, 1404–1409 (1972).
E. S. C. Wu, T. E. Cole, T. A. Davidson, et al., J. Med. Chem.,30, 788–792 (1987).
Y. Yabuuchi and D. Kinoshita, Jpn. J. Pharmacol.,6, 853–861 (1974).
Author information
Authors and Affiliations
Additional information
Translated from Khimiko-farmatsevticheskii Zhurnal, Vol. 25, No. 5 pp. 21–31, May, 1991.
Rights and permissions
About this article
Cite this article
Yuzhakov, S.D., Glushkov, R.G. & Mashkovskii, M.D. Structure-activity relationships in β-adrenoblockers. Pharm Chem J 25, 283–295 (1991). https://doi.org/10.1007/BF00772116
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00772116